NASDAQ
Enzo Biochem, Inc. (ENZB) has a current ratio of 2.82x as of Tuesday, May 26, 2026. This represents a 19.19% increase compared to its 12-month average of 2.37x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.